Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0WMPDO
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
111In-DOTA-5D3
|
|||||
| Synonyms |
<sup>111</sup>In DOTA 5D3; <sup>111</sup>InDOTA5D3;
Click to Show/Hide
|
|||||
| Organization |
The Johns Hopkins University
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Prostate cancer [ICD11:2C82]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
0-1
|
|||||
| Antibody Name |
Anti-PSMA mAb 5D3
|
Antibody Info | ||||
| Antigen Name |
Glutamate carboxypeptidase 2 (FOLH1)
|
Antigen Info | ||||
| Payload Name |
Indium-111
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Tetraxetan
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.